Treatment with Methotrexate, Rituximab, and Cytosine Arabinoside Followed by Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: A Single-center Experience
Conclusion R–MTX–ARA-C followed by autologous stem cell transplantation seems a promising strategy with high response rates in PCNSL.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Lymphoma | Methotrexate | Middle East Health | Primary CNS Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants